Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Amphetamine

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk

Tardelli V, Xu KY, Bisaga A, et al

BMJ Ment Health 2023;26:e300728. 

https://mentalhealth.bmj.com/content/26/1/e300728